Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin in Resected NSCLC (TILT)
NCT00475098Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2007
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tinzaparin in non-small cell lung cancer (NSCLC), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2007; status: completed.
02
Drugs
tinzaparin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00475098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475098.